WebPage 1/8 Safety Data Sheet acc. to OSHA HCS Printing date 08/17/2024 Revision date 08/17/2024 53.1.21 1 Identification · Product identifier · Trade name: Carboxyphosphamide · Article number: 34052 · CAS Number: 22788-18-7 · Application of the substance / the mixture This product is for research use - Not for human or veterinary … WebNov 18, 1992 · Carboxyphosphamide is an inactive metabolite of cyclophosphamide, which is a widely used antineoplastic drug. Deficiencies in the production of this …
Georg PHD Goethe-Universität Frankfurt am Main ... - ResearchGate
WebPlasma concentrations of cyclophosphamide and the metabolites 4-ketocyclophosphamide, dechloroethylcyclophosphamide and carboxyphosphamide were determined on days 1, 2 and 3 of each course. A population pharmacokinetic model for cyclophosphamide was developed using non-linear mixed effects modelling and metabolite AUC values were … WebJul 31, 2024 · Cyclophosphamide is activated to form 4-hydroxycyclophosphamide, which is in equilibrium with its ring-open tautomer aldophosphamide. 4-hydroxycyclophosphamide and aldophosphamide can undergo oxidation by aldehyde dehydrogenases to form the inactive metabolites 4-ketocyclophosphamide and carboxyphosphamide, respectively. conseco finance consumer discount company
Aldophosphamide - an overview ScienceDirect Topics
WebCarboxycyclophosphamide is an inactive metabolite of the cytotoxic antineoplastic drug cyclophosphamide. In the metabolic pathway of cyclophosphamide inactivation it first … Webcarboxyphosphamide, a compound with weaker antineoplastic capabilities, which is the primary recoverable urinary constituent of the drug. '',19 Interestingly, the phosphamidase activity necessary for the initial conversion in the liver has been demonstrated in the urothelium of the rat bladder. 26 WebFeb 3, 2004 · Carboxyphosphamide and dechloroethylcyclophosphamide were detected in eight children (22%). Measured metabolite AUC varied from not detectable to 206 μ m ·h and not detectable to 181 μ m ·h, respectively. Both carboxyphosphamide and dechloroethylcyclophosphamide appeared in all of the patients in whom metabolites … editing footer in powerpoint